Randomized, Double-blinded, Active Controlled, Phase I/II Clinical Trial to Assess the Safety, Tolerability and Immunogenicity of NBP613 in Healthy Infants
Randomized, Double-blinded, Active Controlled, Phase I/II Clinical Trial to Assess the Safety, Tolerability and Immunogenicity of NBP613 in Healthy Infants
Investigator :
เพณณินาท์ โอเบอร์ดอร์เฟอร์